
CME Group (CME) Stock Forecast & Price Target
CME Group (CME) Analyst Ratings
Bulls say
CME Group reported a record revenue of $1.7 billion, reflecting a 10% year-over-year increase, which was supported by robust performance in Clearing & Transaction and Market Data revenue. The company experienced significant growth in international volumes, particularly in EMEA and APAC, with increases of 15% and 30% year-over-year, respectively, and added over 90,000 new retail traders, marking a 56% year-over-year rise. Additionally, CME's strategic positioning to benefit from rising interest rates and the anticipated earnings boost, coupled with strong demand for its capital efficiency offerings, underpins a positive outlook for the company.
Bears say
CME Group faces several challenges that contribute to a negative outlook on its stock. The potential for declining open interest (OI) signals a risk of deteriorating market sentiment and financial conditions, which could adversely affect trading volumes and, consequently, revenues. Additionally, increased regulatory scrutiny and the prospect of low market volatility further threaten the company's ability to maintain robust trading activity, ultimately impacting its financial performance given the interconnected nature of market volumes and CME's revenue model.
This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.
CME Group (CME) Analyst Forecast & Price Prediction
Start investing in CME Group (CME)
Order type
Buy in
Order amount
Est. shares
0 shares